RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...

In prostate cancer, Pfizer’s Talzenna already holds the broadest FDA approval within the PARP inhibitor class. | In prostate ...

Sanofi said it entered into talks with Clayton Dubilier & Rice to offload a controlling stake in its consumer-health division, leaning toward a partial sale to a private-equity firm rather than a ...

Sanofi is in talks to sell a 50% controlling stake in its consumer health unit to CD&R. It is set to be one of the biggest deals this year, following similar moves by big pharma peers GSK Plc, ...

Two former Pfizer executives said they will not be involved with activist investor Starboard Value, which reportedly wants ...

Sanofi SA is in talks to sell a 50% controlling stake in its consumer health business to Clayton Dubilier & Rice, as the ...

The French drugmaker laid out plans to separate its consumer division--home to brands such as Allegra, Dulcolax and IcyHot--from its innovative medicines and vaccines businesses a year ago. With its ...

GSK shares rose after the British drug major agreed to pay up to $2.2 billion to settle thousands of U.S. lawsuits over claims its discontinued heartburn medicine Zantac caused cancer. Write to Rob ...

With its decision, Sanofi joined peers Johnson & Johnson, Pfizer and GSK in hiving off businesses that sell over-the-counter ...

The latest health news includes Illumina's launch of affordable gene sequencers, Pfizer's promising cancer drug trials, CVS ...

The need for antiemetic drugs, which help prevent or relieve nausea and vomiting, is growing for several reasons. A key factor is the rising incidence of conditions and treatments that cause these ...

Pfizer Inc. company officials threatened legal action against two former top executives who had been working with Starboard ...